Accessible Care Model Improves HCV Cure Rates Compared With Facilitated Referral Standard Care Model In Patients With HCV Who Inject Drugs, Trial Indicates
May 16, 2022
Gastroenterology Advisor (5/13, Champagne) reported “patients with hepatitis C virus (HCV) who inject drugs are more likely to achieve HCV cure when using an accessible care model compared with a facilitated referral standard care model, according to” a “...